SARS-CoV-2 vaccine safely induces an immune response in healthy volunteers  European Pharmaceutical ReviewView Full coverage on Google News
The Chinese COVID-19 vaccine BBIBP-CorV elicited an antibody response in all recipients, according to preliminary Phase I/II trial data.The Chinese COVID-19 vaccine BBIBP-CorV elicited an antibody response in all recipients, according to preliminary Phase I/II trial data.

SARS-CoV-2 vaccine safely induces an immune response

BEIJING (Reuters) - A Chinese city is offering Sinovac Biotech's <SVA.O> experimental COVID-19 vaccine to essential workers and other high-risk groups as part of a national programme for about $60 (£46).BEIJING (Reuters) - A Chinese city is offering Sinovac Biotech's <SVA.O> experimental COVID-19 vaccine to essential workers and other high-risk groups as part of a national programme for about $60 (£46).

Sinovac coronavirus vaccine offered by Chinese city for emergency use costs $60 | The Star

NO side effects have been recorded thus far, as the development of the Covid-19 vaccine between Indonesia and China progresses.

Indonesia-China vaccine trials run smoothly | New Straits Times

BEIJING, Oct 16 — One of China’s front-running coronavirus vaccine candidates was shown to be safe and triggered immune responses in a combined early and mid-stage test in humans, researchers said. The potential vaccine, dubbed BBIBP-CorV, is being developed by the Beijing Institute of...BEIJING, Oct 16 — One of China’s front-running coronavirus vaccine candidates was shown to be safe and triggered immune responses in a combined early and mid-stage test in humans, researchers said. The potential vaccine, dubbed BBIBP-CorV, is being developed by the Beijing Institute of...

Study: Covid-19 vaccine candidate from China’s CNBG shows promise in human test | Life | Malay Mail

Key workers and those at high risk from COVID-19 would be among the first to receive the jabs in the city of Jiaxing. Others include residents aged between 18 and 59 with 'urgent need for vaccination'.Key workers and those at high risk from COVID-19 would be among the first to receive the jabs in the city of Jiaxing. Others include residents aged between 18 and 59 with 'urgent need for vaccination'.

Coronavirus: Experimental £46 COVID-19 vaccine is made available to residents of Chinese city | Daily Mail Online

Treatment is safe and elicits an antibody response, preliminary results have shownTreatment is safe and elicits an antibody response, preliminary results have shown

'Enouraging' Chinese Covid vaccine shows early promise - Hull Live

403 Missing Auth Token

COVID-19 vaccine, and China-Africa health cooperation, are their focus.

50 African diplomats visit Chinese coronavirus vaccine maker - CGTN

50 African diplomats visited China’s human vaccine research, development, and manufacturing enterprise Sinopharm in the fight against covid-1950 African diplomats visited China’s human vaccine research, development, and manufacturing enterprise Sinopharm in the fight against covid-19

50 African Diplomats on Anti-Covid-19 Visit to China’s Sinopharm | Africanews

A Chinese COVID-19 vaccine candidate based on the inactivated whole SARS-CoV-2 virus (BBIBP-CorV) is safe and elicits an antibody response, findings from a small early-phase randomised clinical trial ...

Preliminary results find COVID-19 vaccine candidate based on inactivated SARS-CoV-2 virus is safe

Chinese Covid-19 vaccine candidate -- BBIBP-CorV -- that is expected to completely inactivate the SARS-CoV-2 virus, is safe and elicits an antibody response, a study published in The Lancet has found.Chinese Covid-19 vaccine candidate -- BBIBP-CorV -- that is expected to completely inactivate the SARS-CoV-2 virus, is safe and elicits an antibody response, a study published in The Lancet has found.

China's Covid-19 vax is safe, prompts antibody response: Lancet | greatandhra.com

THE QUEEN could play a key role if a coronavirus vaccine becomes available, according to an expert.THE QUEEN could play a key role if a coronavirus vaccine becomes available, according to an expert.

Queen news: Queen could play key role if coronavirus vaccine becomes available - expert | Royal | News | Express.co.uk

NewZimbabwe.com – The Zimbabwe News You Trust is Zimbabwe’s leading online newspaper and published by New Zimbabwe Media Ltd. The platform brings you the latest breaking News, Business, Showbiz, Sports, Diaspora and gives you everything you’ve come to expect and love.Spread This NewsMailOnLine Hopes of getting a Covid-19 vaccine were boosted again today after an experimental Chinese jab was found to be safe and produce an immune response. Every volunteer given a double-dose of state-owned firm Sinopharm’s vaccine made antibodies against SARS-CoV-2, the coronavirus that causes Covid-19. In theory, this would protect them from catching

More Covid-19 vaccine hopes as scientists say experimental Chinese jab is safe - NewZimbabwe.com

China News: TAIPEI: China is rapidly increasing the number of people receiving its experimental coronavirus vaccines, with a city offering one to the general publ.China News: TAIPEI: China is rapidly increasing the number of people receiving its experimental coronavirus vaccines, with a city offering one to the general publ.

China Coronavirus Vaccine: China rapidly expands use of experimental Covid-19 vaccines | World News - Times of India

A previous clinical trial reported similar results for a different vaccine that is also based on inactivated whole SARS-CoV-2 virus, but in that study the vaccine was only tested in people aged under 60 years. The latest study, published in The Lancet Infectious Diseases journal, included participants aged between 18 and 80 years, and found that antibody responses were induced in all recipients.A previous clinical trial reported similar results for a different vaccine that is also based on inactivated whole SARS-CoV-2 virus, but in that study the vaccine was only tested in people aged under 60 years. The latest study, published in The Lancet Infectious Diseases journal, included participants aged between 18 and 80 years, and found that antibody responses were induced in all recipients.

Chinese COVID-19 vaccine candidate shows promise in human trial: Study | Health

Health authorities in Jiaxing, East China’s Zhejiang Province, announced on Thursday that the city has been administering China’s homegrown inactivated COVID-19 vaccines among high-risk groups and would gradually offer it to ordinary citizens for urgent use.

Eastern Chinese cities to offer ordinary citizens COVID-19 vaccines - Global Times

A $60 double-dose experimental coronavirus vaccine is being made available to some residents in an eastern Chinese city, health officials have said, the first details of a mass rollout for an as-yet unproven vaccine. Officials in Jiaxing city said Thursday residents aged between 18 and 59 with "urgent needs" can seek consultations at clinics for a Sinovac Biotech vaccine thatA $60 double-dose experimental coronavirus vaccine is being made available to some residents in an eastern Chinese city, health officials have said, the first details of a mass rollout for an as-yet

$60 experimental coronavirus vaccine rolled out in eastern Chinese city | Deccan Herald

China is positioning itself to be key to any global solution to the pandemic.. Read more at straitstimes.com.East Asia News -China is positioning itself to be key to any global solution to the pandemic.. Read more at straitstimes.com.

Beijing in Covid-19 vaccine race to restore international image, East Asia News & Top Stories - The Straits Times

The move is aimed at boosting public confidence in homegrown inoculations, the WSJ reported, citing a company website and some students who applied for it.

China's Sinopharm Offers Experimental COVID-19 Vaccines to Students - The Wire Science

Participants aged 60 and older were slower to respond, taking 42 days before antibodies were detected in all recipients compared with 28 days for participants aged 18-59Participants aged 60 and older were slower to respond, taking 42 days before antibodies were detected in all recipients compared with 28 days for participants aged 18-59

Preliminary results show Chinese Covid-19 vaccine candidate safe | Dhaka Tribune

Hope for a coronavirus vaccine have been boosted after a Chinese jab proved to be safe and produced an antibody response, scientists have said. The research, published in the journal Lancet Infectious Disease, is based on small early phase randomised clinical trials involving 640 participants. The vaccine candidate is based on inactivated coronavirus. Scientists said thoseHope for a coronavirus vaccine have been boosted after a Chinese jab proved to be safe and produced an antibody response, scientists have said. The research, published in the journal Lancet

Hope for coronavirus vaccine boosted as scientists say Chinese jab safe and produces immune response | London Evening Standard

The Beijing-based Sinovac Biotech’s vaccine — called CoronaVac — is being offered in the city of Jiaxing to care givers, especially epidemic-prevention workers, public service personnel and port inspectors, and will eventually be offered to regular citizens, the state media reported on Friday, quoting officials.The Beijing-based Sinovac Biotech’s vaccine — called CoronaVac — is being offered in the city of Jiaxing to care givers, especially epidemic-prevention workers, public service personnel and port inspectors, and will eventually be offered to regular citizens, the state media reported on Friday, quoting officials.

Sinovac vaccine for Covid offered by Chinese city for emergency use costs $60 - world news - Hindustan Times

Researchers said those aged 60 and over were slower to respond to the BBIBP-CorV vaccine.Researchers said those aged 60 and over were slower to respond to the BBIBP-CorV vaccine.

Chinese Covid-19 vaccine candidate 'safely triggers antibody response' | ITV News

Clinical trials of the coronavirus vaccine have involved 640 peopleClinical trials of the coronavirus vaccine have involved 640 people

Chinese Covid-19 vaccine candidate safe, early reports say | Metro News

Coronavirus vaccine update: The International Monetary Fund (IMF) has said that international cooperation on a coronavirus vaccine could boost the global economy by $9 trillion to pull it out of the economic crisis. Meanwhile, in the global vaccine race, a Chinese vaccine has shown positive results in the human test.Coronavirus vaccine update: The International Monetary Fund (IMF) has said that international cooperation on a coronavirus vaccine could boost the global economy by $9 trillion to pull it out of the economic crisis. Meanwhile, in the global vaccine race, a Chinese vaccine has shown positive results in the human test.

Coronavirus vaccine update: Chinese vaccine shows positive results, US probing Vaxart claims - Coronavirus Outbreak News

China has begun inoculating the general public against the coronavirus with an experimental vaccine that has not yet completed clinical trials.Health officials in Jiaxing, Zhejiang province, said theChina has begun inoculating the general public against the coronavirus with an experimental vaccine that has not yet completed clinical trials.Health officials in Jiaxing, Zhejiang province, said the

Researchers caution that levels of antibodies produced in participants aged over 60 were lower and took longer to increase, however Researchers caution that levels of antibodies produced in participants aged over 60 were lower and took longer to increase, however 

Chinese coronavirus vaccine shows promising results in human tests, study shows | The Independent

The site of the COVID-19 vaccine trial in Savannah was visited by state and federal officials on Friday.The site of the COVID-19 vaccine trial in Savannah was visited by state and federal officials on Friday.

HHS, Gov. Kemp visit Savannah site conducting COVID-19 vaccine trials | WSAV-TV

This vaccine includes the killed virus mixed with aluminium hydroxide, which is known to boost immune responses.This vaccine includes the killed virus mixed with aluminium hydroxide, which is known to boost immune responses.

China's Covid-19 vaccine candidate is safe and prompts antibody response - early results from study

Officials in Jiaxing city said residents with urgent needs can seek vaccination in the first mass roll-out.Officials in Jiaxing city said residents with urgent needs can seek vaccination in the first mass roll-out.

Covid-19: China rolls out $60 experimental vaccine for residents - News | Khaleej Times

The Indonesian government has secured a supply of those vaccines, including 143 million doses of Sinovac vaccineThe Indonesian government has secured a supply of those vaccines, including 143 million doses of Sinovac vaccine

Indonesian Team in China for Covid-19 Vaccine Safety Audit

A €50 double-dose experimental coronavirus vaccine is being made available to some residents in an eastern Chinese city, health officials have said, the first details of a mass rollout for an as-yet unproven vaccine. Officials in Jiaxing city said that residents aged between 18 and 59 with...A €50 double-dose experimental coronavirus vaccine is being made available to some residents in an eastern Chinese city, health officials have said, the first details of a mass rollout for an as-yet unproven vaccine. Officials in Jiaxing city said that residents aged between 18 and 59 with...

€50 experimental COVID-19 vaccine rolled out in east Chinese city

Indonesia is taking steps toward approving emergency usage of Covid-19 vaccine candidates from China, undefineda senior health official said, a move that would make it the second country outside China to do so.Indonesia is taking steps toward approving emergency usage of Covid-19 vaccine candidates from China, undefineda senior health official said, a move that would make it the second country outside China to do so.

Indonesia Weighs Approving Chinese Covid-19 Vaccines for Emergency Use - WSJ

China National Biotec Group is distributing its vaccine outside clinical trials, per The Wall Street Journal. Experts say this is incredibly risky.China National Biotec Group is distributing its vaccine outside clinical trials, per The Wall Street Journal. Experts say this is incredibly risky.

Chinese firm giving unproven COVID-19 vaccine to students going abroad - Business Insider

The vaccine, BBIBP-CorV, includes the killed virus mixed with another component, aluminium hydroxide, which is an adjuvant as it is known to boost immune responses.The vaccine, BBIBP-CorV, includes the killed virus mixed with another component, aluminium hydroxide, which is an adjuvant as it is known to boost immune responses.

Chinese Covid vaccine safe in phase 1 & 2 trials, generates antibodies, Lancet says

The vaccine, BBIBP-CorV, includes the killed virus mixed with another component, aluminium hydroxide, which is an adjuvant as it is known to boost immune responses.The vaccine, BBIBP-CorV, includes the killed virus mixed with another component, aluminium hydroxide, which is an adjuvant as it is known to boost immune responses.

Chinese Covid vaccine safe in phase 1 & 2 trials, generates antibodies, Lancet says

China is now offering an experimental "emergency-use" coronavirus vaccine that has yet to pass standard testing to students heading overseas to study, according to reports.China is offering an experimental “emergency-use” coronavirus vaccine that has yet to pass standard testing to students heading overseas to study, according to reports. The state-owned

China giving untested COVID-19 vaccines to study abroad students

A 50 euro double-dose experimental coronavirus vaccine has been made available to some residents in an eastern Chinese city, according to health officials, in the first mass distribution of an as-yet…A 50 euro double-dose experimental coronavirus vaccine has been made available to some residents in an eastern Chinese city, according to health officials, in the first mass distribution of an as-yet…

China starts distributing experimental Covid vaccine in eastern Jiaxing

China's Covid-19 vaccine is safe, prompts antibody response: Lancet Greater Kashmir | Chinese Covid-19 vaccine candidate -- BBIBP-CorV -- that is expected to completely inactivate the SARS-CoV-2 virus, is safe and elicits an antibodyChina's Covid-19 vaccine is safe, prompts antibody response: Lancet Greater Kashmir | Chinese Covid-19 vaccine candidate -- BBIBP-CorV -- that is expected to completely inactivate the SARS-CoV-2 virus, is safe and elicits an antibody

China's Covid-19 vaccine is safe, prompts antibody response: Lancet | Greater Kashmir

A previous clinical trial reported similar results for a different vaccine that is also based on inactivated whole SARS-CoV-2 virus, but in that study the vaccine was only tested on people aged under 60 years.A previous clinical trial reported similar results for a different vaccine that is also based on inactivated whole SARS-CoV-2 virus, but in that study the vaccine was only tested on people aged under 60 years.

China's Covid-19 Vaccine 'BBIBP-CorV' is Safe, Prompts Antibody Response: Lancet Study

A Chinese city is offering Sinovac Biotech's experimental COVID-19 vaccine to essential workers and other high-risk groups as part of a national programme for about $60. The eastern city of Jiaxin's center for disease control and prevention (CDC) said in a statement on WeChat that two doses of the vaccine…A Chinese city is offering Sinovac Biotech's experimental COVID-19 vaccine to essential workers and other high-risk groups as part of a national programme for about $60. The eastern city of Jiaxin's center for disease control and prevention (CDC) said in a statement on WeChat that two doses of the vaccine…

Chinese city starts offering experimental vaccine for $60 | Cyprus Mail